Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma
Clinical trial NCT03540303 · UNKNOWN
Trial details
- NCT number
- NCT03540303
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-12
- Primary completion
- 2020-04-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.